Back to search

Ireland· IE-PA-EU/1/02/223/001

Evra 203 micrograms/24 hours + 33.9 micrograms/24 hours transdermal patch

A progestogens and estrogens, fixed combinations product containing norelgestromin + ethinylestradiol, registered in Ireland by Gedeon Richter Plc. The same ATC class is registered in 3 of our 19 countries.

ATC G03AA

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedEvra 203 micrograms/24 hours + 33.9 m…ATCG03AAREGISTER NO.IE-PA-EU/1/02/223/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Norelgestromin + ethinylestradiol is registered in 3 of 19 countries.

Countries holding a registration under ATC G03AA (progestogens and estrogens, fixed combinations), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 2 of them publish a price we can compare per daily dose

Norelgestromin + ethinylestradiol · ATC G03AA

3 / 19 countries

  • Belgiumprice
  • Ireland
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Norelgestromin + Ethinylestradiol
Manufacturer
Gedeon Richter Plc
Country
Ireland (IE)
ATC code
G03AA
ATC class
Progestogens and estrogens, fixed combinations
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/02/223/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Norelgestromin + ethinylestradiol in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All norelgestromin + ethinylestradiol products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Evra
  • Liechtenstein · Evra
  • Norway · Evra

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c92dd23f-de63-419a-8f3e-d2a7c8e96eac
GET /v1/drugs/c92dd23f-de63-419a-8f3e-d2a7c8e96eac?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Transdermal patch",
  "routes": null,
  "source": "hpra",
  "atc_all": [
    "G03AA"
  ],
  "strength": null,
  "pa_number": "EU/1/02/223/001",
  "substances": [
    "Norelgestromin",
    "Ethinylestradiol"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "22/08/2002",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about norelgestromin + ethinylestradiol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.